EVOLUS, INC. Investing Cash Flow
EVOLUS, INC. (EOLS) reported Investing Cash Flow of -$2.19 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivities · last filed 2026-08-05
- EVOLUS, INC. net cash provided by (used in) investing activities for the quarter ending 2026-06-30 was -$500.00K.
- EVOLUS, INC. net cash provided by (used in) investing activities for the quarter ending 2026-03-31 was -$1.69M.
- EVOLUS, INC. net cash provided by (used in) investing activities for the quarter ending 2025-12-31 was -$2.17M.
- EVOLUS, INC. net cash provided by (used in) investing activities for the quarter ending 2025-09-30 was -$2.16M.
- EVOLUS, INC. net cash provided by (used in) investing activities for fiscal 2025 was -$8.45M.
- EVOLUS, INC. net cash provided by (used in) investing activities for fiscal 2024 was -$4.82M.
- EVOLUS, INC. net cash provided by (used in) investing activities for fiscal 2023 was -$1.63M.
- EVOLUS, INC. net cash provided by (used in) investing activities for fiscal 2022 was -$2.94M, a 172.93% decline from fiscal 2021.
| Period end | Net Cash Provided by (Used in) Investing Activities 3 month | Net Cash Provided by (Used in) Investing Activities 6 month | Net Cash Provided by (Used in) Investing Activities 9 month | Net Cash Provided by (Used in) Investing Activities 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$500.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | -$2.19M 10-Q · filed 2026-08-05 | -$4.36M derived: sum of 3 quarters · filed 2026-08-05 | -$6.51M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | -$1.69M 10-Q · filed 2026-05-04 | -$3.86M derived: sum of 2 quarters · filed 2026-05-04 | -$6.01M derived: sum of 3 quarters · filed 2026-05-04 | -$8.28M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | -$2.17M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | -$4.32M derived: sum of 2 quarters · filed 2026-03-03 | -$6.59M derived: sum of 3 quarters · filed 2026-08-05 | -$8.45M 10-K · filed 2026-03-03 |
| 2025-09-30 | -$2.16M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | -$4.42M derived: sum of 2 quarters · filed 2026-08-05 | -$6.29M 10-Q · filed 2025-11-05 | -$7.65M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | -$2.27M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | -$4.13M 10-Q · filed 2026-08-05 | -$5.49M derived: sum of 3 quarters · filed 2026-08-05 | -$6.90M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | -$1.86M 10-Q · filed 2026-05-04 | -$3.22M derived: sum of 2 quarters · filed 2026-05-04 | -$4.63M derived: sum of 3 quarters · filed 2026-05-04 | -$5.89M derived: sum of 4 quarters · filed 2026-05-04 |
| 2024-12-31 | -$1.36M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | -$2.77M derived: sum of 2 quarters · filed 2026-03-03 | -$4.03M derived: sum of 3 quarters · filed 2026-03-03 | -$4.82M 10-K · filed 2026-03-03 |
| 2024-09-30 | -$1.41M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | -$2.66M derived: sum of 2 quarters · filed 2025-11-05 | -$3.46M 10-Q · filed 2025-11-05 | -$3.82M derived: sum of 4 quarters · filed 2026-03-03 |
| 2024-06-30 | -$1.25M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | -$2.05M 10-Q · filed 2025-08-05 | -$2.41M derived: sum of 3 quarters · filed 2026-03-03 | -$2.95M derived: sum of 4 quarters · filed 2026-03-03 |
| 2024-03-31 | -$797.00K 10-Q · filed 2025-05-07 | -$1.16M derived: sum of 2 quarters · filed 2026-03-03 | -$1.70M derived: sum of 3 quarters · filed 2026-03-03 | -$1.91M derived: sum of 4 quarters · filed 2026-03-03 |
| 2023-12-31 | -$361.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | -$900.00K derived: sum of 2 quarters · filed 2026-03-03 | -$1.12M derived: sum of 3 quarters · filed 2026-03-03 | -$1.63M 10-K · filed 2026-03-03 |
| 2023-09-30 | -$539.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | -$755.00K derived: sum of 2 quarters · filed 2024-11-06 | -$1.27M 10-Q · filed 2024-11-06 | -$2.66M derived: sum of 4 quarters · filed 2025-03-04 |
| 2023-06-30 | -$216.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-31 | -$727.00K 10-Q · filed 2024-07-31 | -$2.12M derived: sum of 3 quarters · filed 2025-03-04 | -$3.02M derived: sum of 4 quarters · filed 2025-03-04 |
| 2023-03-31 | -$511.00K 10-Q · filed 2024-05-07 | -$1.90M derived: sum of 2 quarters · filed 2025-03-04 | -$2.80M derived: sum of 3 quarters · filed 2025-03-04 | -$3.19M derived: sum of 4 quarters · filed 2025-03-04 |
| 2022-12-31 | -$1.39M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-04 | -$2.29M derived: sum of 2 quarters · filed 2025-03-04 | -$2.68M derived: sum of 3 quarters · filed 2025-03-04 | -$2.94M 10-K · filed 2025-03-04 |
| 2022-09-30 | -$899.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | -$1.29M derived: sum of 2 quarters · filed 2023-11-07 | -$1.55M 10-Q · filed 2023-11-07 | -$1.94M derived: sum of 4 quarters · filed 2023-11-07 |
| 2022-06-30 | -$388.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-02 | -$649.00K 10-Q · filed 2023-08-02 | -$1.04M derived: sum of 3 quarters · filed 2023-08-02 | -$1.02M derived: sum of 4 quarters · filed 2023-08-02 |
| 2022-03-31 | -$261.00K 10-Q · filed 2023-05-09 | -$651.00K derived: sum of 2 quarters · filed 2023-05-09 | -$630.00K derived: sum of 3 quarters · filed 2023-05-09 | -$1.02M derived: sum of 4 quarters · filed 2023-05-09 |
| 2021-12-31 | -$390.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-08 | -$369.00K derived: sum of 2 quarters · filed 2023-03-08 | -$755.00K derived: sum of 3 quarters · filed 2023-03-08 | $4.03M 10-K · filed 2023-03-08 |
| 2021-09-30 | $21.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | -$365.00K derived: sum of 2 quarters · filed 2022-11-08 | $4.42M 10-Q · filed 2022-11-08 | $24.12M derived: sum of 4 quarters · filed 2022-11-08 |
| 2021-06-30 | -$386.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-02 | $4.40M 10-Q · filed 2022-08-02 | $24.10M derived: sum of 3 quarters · filed 2022-08-02 | $53.40M derived: sum of 4 quarters · filed 2022-08-02 |
| 2021-03-31 | $4.79M 10-Q · filed 2022-05-10 | $24.49M derived: sum of 2 quarters · filed 2022-05-10 | $53.79M derived: sum of 3 quarters · filed 2022-05-10 | $63.17M derived: sum of 4 quarters · filed 2022-05-10 |
| 2020-12-31 | $19.70M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-03 | $49.00M derived: sum of 2 quarters · filed 2022-03-03 | $58.38M derived: sum of 3 quarters · filed 2022-03-03 | $12.19M 10-K · filed 2022-03-03 |
| 2020-09-30 | $29.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-02 | $38.68M derived: sum of 2 quarters · filed 2021-11-02 | -$7.51M 10-Q · filed 2021-11-02 | $6.47M derived: sum of 4 quarters · filed 2021-11-02 |
| 2020-06-30 | $9.38M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-04 | -$36.81M 10-Q · filed 2021-08-04 | -$22.83M derived: sum of 3 quarters · filed 2021-08-04 | $11.56M derived: sum of 4 quarters · filed 2021-08-04 |
| 2020-03-31 | -$46.19M 10-Q · filed 2021-05-12 | -$32.21M derived: sum of 2 quarters · filed 2021-05-12 | $2.18M derived: sum of 3 quarters · filed 2021-05-12 | $10.40M derived: sum of 4 quarters · filed 2021-05-12 |
| 2019-12-31 | $13.97M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25 | $48.36M derived: sum of 2 quarters · filed 2021-03-25 | $56.59M derived: sum of 3 quarters · filed 2021-03-25 | -$23.43M 10-K · filed 2021-03-25 |
| 2019-09-30 | $34.39M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-29 | $42.62M derived: sum of 2 quarters · filed 2020-10-29 | -$37.41M 10-Q · filed 2020-10-29 | -$37.41M derived: sum of 4 quarters · filed 2020-10-29 |
| 2019-06-30 | $8.23M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | -$71.80M 10-Q · filed 2020-08-10 | -$71.80M derived: sum of 3 quarters · filed 2020-08-10 | -$71.80M derived: sum of 4 quarters · filed 2020-08-10 |
| 2019-03-31 | -$80.03M 10-Q · filed 2020-05-11 | -$80.03M derived: sum of 2 quarters · filed 2020-05-11 | -$80.03M derived: sum of 3 quarters · filed 2020-05-11 | -$80.03M derived: sum of 4 quarters · filed 2020-05-11 |
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | $0.00 derived: sum of 2 quarters · filed 2020-02-25 | -$9.00K derived: sum of 3 quarters · filed 2020-02-25 | -$9.00K 10-K · filed 2020-02-25 |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-04 | -$9.00K derived: sum of 2 quarters · filed 2019-11-04 | -$9.00K 10-Q · filed 2019-11-04 | -$9.00K derived: sum of 4 quarters · filed 2019-11-04 |
| 2018-06-30 | -$9.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-12 | -$9.00K 10-Q · filed 2019-08-12 | -$9.00K derived: sum of 3 quarters · filed 2019-08-12 | -$9.00K derived: sum of 4 quarters · filed 2019-08-12 |
| 2018-03-31 | $0.00 10-Q · filed 2019-05-01 | $0.00 derived: sum of 2 quarters · filed 2019-05-01 | $0.00 derived: sum of 3 quarters · filed 2019-05-01 | |
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-20 | $0.00 derived: sum of 2 quarters · filed 2019-03-20 | $0.00 10-K · filed 2019-03-20 | |
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-05 | $0.00 10-Q · filed 2018-11-05 | ||
| 2017-06-30 | $0.00 10-Q · filed 2018-08-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |